Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
Jin LIU public CV
View Scopus Profile
Jin LIU, Prof
Associate Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0001-6308-6719
Email
liujin
hkbu.edu
hk
Accepting PhD Students
2013
2025
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(6)
Research Output
(73)
Prizes / Awards
(5)
Activities
(23)
Similar Scholars
(6)
Fingerprint
Dive into the research topics where Jin LIU is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Bone Formation
100%
Sclerostin
79%
Aptamer
75%
MicroRNA
64%
Osteoblast
58%
Long Non-coding RNA (LncRNA)
49%
Osteoclast
49%
Aging
46%
Osteoblastic
39%
Osteosarcoma
30%
Rheumatoid Arthritis
29%
Exosomal
29%
RNA Interference
29%
Drug Discovery
29%
Bone Loss
29%
Delivery System
26%
Exosomes
24%
Small Interfering RNA (siRNA)
24%
Osteopenia
23%
BMP Signaling
23%
Smad
23%
Mechanical Unloading
23%
Protective Behavior
22%
ApoER2
21%
Skeletal muscle Atrophy
21%
MiR-214-3p
19%
Casein Kinase 2 Interacting protein-1 (CKIP-1)
19%
Therapeutic Genome Editing
19%
MiR-214
19%
Developmental Dysplasia of the Hip
19%
Breast Cancer Bone Metastasis
19%
Cardiovascular Protective
19%
SELEX
19%
Cartilage
18%
Bone Resorption
18%
Cardiovascular System
18%
Osteoblastic Bone Formation
17%
TRAF3
16%
Muscle Atrophy
16%
Bone Anabolic Effects
16%
Targeted Delivery System
16%
Targeted Drug Delivery
15%
Skeletal Disorders
15%
Metastasis
15%
Osteoclastogenesis
15%
Molecular Mechanism
15%
Age-related
15%
Osteoclastic
15%
Osteogenesis Imperfecta
14%
Mouse Model
14%
Pharmacology, Toxicology and Pharmaceutical Science
Sclerostin
79%
Aptamer
72%
Bone Disease
44%
microRNA
37%
Osteosarcoma
34%
Neoplasm
34%
Messenger RNA
30%
Drug Discovery
29%
Malignant Neoplasm
24%
Breast Cancer
21%
Lung Metastasis
20%
Bone Metastasis
19%
Muscle Atrophy
19%
microRNA 214
19%
Small Interfering RNA
17%
Tumor Necrosis Factor Receptor Associated Factor 3
16%
Cardiovascular Risk
15%
Osteogenesis Imperfecta
14%
Inflammation
14%
Mouse Model
14%
Targeted Drug Delivery
13%
Diseases
13%
Triple Negative Breast Cancer
11%
Bone Destruction
11%
Cytokine
11%
Drug Delivery System
11%
Bone Cancer
11%
Cathepsin K
10%
Clinical Trial
10%
Vasculotropin
9%
Virtual Screening
9%
Osteopenia
9%
Vasculotropin A
9%
Musculoskeletal Disease
9%
Myostatin
9%
Disorders of Lipid and Lipoprotein Metabolism
9%
Nuclease
9%
Clinical Feature
9%
Disorders of Carbohydrate Metabolism
9%
Paclitaxel
9%
Ezrin
9%
Casein Kinase
9%
Synapsin I
9%
Ovary Cancer
9%
Long Untranslated RNA
9%
Fracture Healing
9%
Rheumatoid Arthritis
9%
Inflammatory Arthritis
9%
Bone Erosion
9%
Leflunomide
9%
Medicine and Dentistry
Ossification
54%
Osteolysis
39%
Osteoblast
24%
microRNA
23%
Aptamer
22%
Osteoclast
21%
Osteosarcoma
20%
Long Untranslated RNA
19%
Sclerostin
19%
Genome Editing
19%
Dysplasia
19%
Breast Cancer
19%
Bone Metastasis
19%
Osteopenia
19%
Exosome
19%
Osteoclastogenesis
18%
In Vitro
17%
Osteoarthritis
17%
Lung Metastasis
15%
Isoprenaline
13%
Bone Remodeling
13%
Bone Disease
13%
Small Interfering RNA
13%
Molecular Therapy
11%
Bone Homeostasis
11%
Clustered Regularly Interspaced Short Palindromic Repeat
11%
Cas9
11%
Bone Destruction
11%
Tumor Cell
10%
Arthrogram
9%
Tumor Necrosis Factor Receptor Associated Factor 3
9%
Vasculotropin
9%
Skeletal Muscle
9%
Vascularity
9%
Myokine
9%
Src Inhibitor
9%
Immunocompetent Cell
9%
Vasculotropin A
9%
Nuclease
9%
High Fat Food
9%
Chondrocyte
9%
Cartilage Degeneration
9%
Postmenopause
9%
Rheumatoid Arthritis
9%
Inflammatory Arthritis
9%
Hydroxysteroid Dehydrogenase
9%
Cardiovascular System
9%
Osteotomy
9%
Acetabular
9%
Pelvis Osteotomy
9%
